Study Title

Diagnosis of Renal Cell Carcinoma on 68Ga-PSMA PET-CT and Radioligand Therapy With 177Lu-EB-PSMA-617

Study Details

Description:

Renal Cell Carcinoma (RCC) is the second most common tumor in urology. Considering its origination from kidney, an organ with intense physiological uptake and excretion of 68Ga-PSMA, this study aims to evaluate the uptake of 68Ga-PSMA in RCC compared to 18F-FDG in the same patients, and assess the feasibility of 177Lu-EB-PSMA-617 treatment in patients with the advanced RCC.

Contacts:

Zhaohui Zhu, MD

13611093752@163.com

86-13611093752

Guochang Wang, MD

guochang1007@163.com

86-18516822732

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468